Outset Medical Inc - Asset Resilience Ratio
Outset Medical Inc (OM) has an Asset Resilience Ratio of 46.29% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Outset Medical Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Outset Medical Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see OM total assets.
Liquid Assets Composition Over Time
This chart breaks down Outset Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read OM current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $112.19 Million | 46.29% |
| Total Liquid Assets | $112.19 Million | 46.29% |
Asset Resilience Insights
- Very High Liquidity: Outset Medical Inc maintains exceptional liquid asset reserves at 46.29% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Outset Medical Inc Industry Peers by Asset Resilience Ratio
Compare Outset Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Outset Medical Inc (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Outset Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 50.64% | $133.94 Million | $264.50 Million | +38.07pp |
| 2024-12-31 | 12.57% | $34.67 Million | $275.80 Million | -30.39pp |
| 2023-12-31 | 42.96% | $134.81 Million | $313.80 Million | -10.59pp |
| 2022-12-31 | 53.55% | $214.28 Million | $400.12 Million | +19.65pp |
| 2021-12-31 | 33.91% | $157.14 Million | $463.46 Million | +28.98pp |
| 2020-12-31 | 4.93% | $19.90 Million | $403.83 Million | -32.59pp |
| 2019-12-31 | 37.52% | $33.15 Million | $88.37 Million | -34.95pp |
| 2018-12-31 | 72.47% | $109.52 Million | $151.13 Million | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more